Russell Frank Company’s Novartis NVS Stock Holding History

Russell Frank Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.49M	Buy	84,035 +42,018	+100%	+$2.86M	0.01%	1268
2015 Q4	$3.3M	Sell	42,017 -219,529	-84%	-$17.4M	0.01%	1516
2015 Q3	$21.5M	Buy	+261,546	New	+$23.3M	0.04%	503
2015 Q1	–	Sell	-36,369	Closed	-$3.04M	–	3016
2014 Q4	$3.04M	Sell	36,369 -1,865	-5%	-$155K	0.01%	1554
2014 Q3	$3.23M	Buy	+38,234	New	+$3.09M	0.01%	1526
2014 Q2	–	Sell	-431,706	Closed	-$32.9M	–	2823
2014 Q1	$32.9M	Sell	431,706 -22,933	-5%	-$1.67M	0.06%	366
2013 Q4	$32.7M	Sell	454,639 -56,530	-11%	-$3.93M	0.06%	353
2013 Q3	$35.1M	Sell	511,169 -80,343	-14%	-$5.32M	0.06%	355
2013 Q2	$37.5M	Buy	+591,512	New	+$38.5M	0.07%	335

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Russell Frank Company's NVS Position: Q1 2016 in Review

Russell Frank Company increased its Novartis (NVS) stake by 100% in Q1 2016, buying an estimated $2.86M and bringing the position to 84,035 shares worth $5.49M. The position accounts for 0.01% of the portfolio, ranked #1268.

Russell Frank Company first reported a position in NVS in Q2 2013 and has held it in 9 quarters since. The position peaked at $37.5M in Q2 2013. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Russell Frank Company held 84,035 shares of Novartis worth $5.49M as of Q1 2016.
Russell Frank Company bought 42,018 Novartis shares in Q1 2016, an estimated $2.86M.
Novartis made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1268 holding.
Russell Frank Company first reported a position in Novartis in Q2 2013 and has held it in 9 quarters since.
Russell Frank Company's Novartis position peaked at $37.5M in Q2 2013.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.